Zobrazeno 1 - 10 of 288 pro vyhledávání: '"Vizcardo R"'
1
Akademický článek
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells.
Autor: Islam SMR; Surgery Branch, NCI, NIH, Bethesda, Maryland.; Center for Cell-Based Therapy, NCI, NIH, Bethesda, Maryland., Maeda T; Surgery Branch, NCI, NIH, Bethesda, Maryland.; Center for Cell-Based Therapy, NCI, NIH, Bethesda, Maryland., Tamaoki N; Surgery Branch, NCI, NIH, Bethesda, Maryland.; Center for Cell-Based Therapy, NCI, NIH, Bethesda, Maryland., Good ML; Surgery Branch, NCI, NIH, Bethesda, Maryland.; Center for Cell-Based Therapy, NCI, NIH, Bethesda, Maryland., Kishton RJ; Surgery Branch, NCI, NIH, Bethesda, Maryland.; Center for Cell-Based Therapy, NCI, NIH, Bethesda, Maryland., Paria BC; Surgery Branch, NCI, NIH, Bethesda, Maryland., Yu Z; Surgery Branch, NCI, NIH, Bethesda, Maryland., Bosch-Marce M; Surgery Branch, NCI, NIH, Bethesda, Maryland., Bedanova NM; Experimental Pathology Laboratory, NCI, NIH, Bethesda, Maryland., Liu C; Transgenic Core, Division of Intramural Research, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland., Kruhlak MJ; CCR Microscopy Core Facility, NCI, NIH, Bethesda, Maryland., Restifo NP; Surgery Branch, NCI, NIH, Bethesda, Maryland.; Center for Cell-Based Therapy, NCI, NIH, Bethesda, Maryland., Vizcardo R; Surgery Branch, NCI, NIH, Bethesda, Maryland.; Center for Cell-Based Therapy, NCI, NIH, Bethesda, Maryland.
Publikováno v: Cancer research communications [Cancer Res Commun] 2023 May 25; Vol. 3 (5), pp. 917-932. Date of Electronic Publication: 2023 May 25 (Print Publication: 2023).
Zobrazit plný text záznamu
2
Akademický článek
Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells.
Autor: Tamaoki N; Surgery Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Center of Cell-based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Siebert S; Department of Molecular and Cellular Biology, University of California, Davis, Davis, CA 95616, USA., Maeda T; Surgery Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Center of Cell-based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Ha NH; Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Good ML; Surgery Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Center of Cell-based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Huang Y; Surgery Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Center of Cell-based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Vodnala SK; Surgery Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Center of Cell-based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Haro-Mora JJ; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA., Sweeney CL; Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Choi U; Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Brault J; Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Koontz S; Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Malech HL; Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Yamazaki Y; Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Isonaka R; Autonomic Medicine Section, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA., Goldstein DS; Autonomic Medicine Section, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA., Kimura M; Division of Gastroenterology, Hepatology & Nutrition, Developmental Biology, Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA., Takebe T; Division of Gastroenterology, Hepatology & Nutrition, Developmental Biology, Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.; Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), and Division of Stem Cell and Organoid Medicine, Osaka University, Suita, Osaka 565-0871, Japan., Zou J; iPSC Core, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA., Stroncek DF; Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD 20892, USA., Robey PG; Skeletal Biology Section, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892, USA., Kruhlak MJ; Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Restifo NP; Surgery Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Center of Cell-based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Vizcardo R; Surgery Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Center of Cell-based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Publikováno v: Cell reports methods [Cell Rep Methods] 2023 Apr 24; Vol. 3 (4), pp. 100460. Date of Electronic Publication: 2023 Apr 24 (Print Publication: 2023).
Zobrazit plný text záznamu
3
Akademický článek
Next generation immunotherapy: enhancing stemness of polyclonal T cells to improve anti-tumor activity.
Autor: Kishton RJ; Lyell Immunopharma Inc., South San Francisco, CA, USA. Electronic address: rkishton@lyell.com., Vodnala SK; Lyell Immunopharma Inc., South San Francisco, CA, USA., Vizcardo R; Lyell Immunopharma Inc., South San Francisco, CA, USA., Restifo NP; Lyell Immunopharma Inc., South San Francisco, CA, USA. Electronic address: nrestifo@lyell.com.
Publikováno v: Current opinion in immunology [Curr Opin Immunol] 2022 Feb; Vol. 74, pp. 39-45. Date of Electronic Publication: 2021 Oct 26.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Correction to: Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation.
Autor: Demirci S; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Haro-Mora JJ; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Leonard A; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Drysdale C; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Malide D; Light Microscopy Core Facility, NHLBI, NIH, Bethesda, MD, USA., Keyvanfar K; Clinical Flow Core Facility, NHLBI, NIH, Bethesda, MD, USA., Essawi K; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Vizcardo R; National Cancer Institute, Center for Cancer Research, NIH, Bethesda, MD, USA., Tamaoki N; National Cancer Institute, Center for Cancer Research, NIH, Bethesda, MD, USA., Restifo NP; National Cancer Institute, Center for Cancer Research, NIH, Bethesda, MD, USA., Tisdale JF; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA. johntis@mail.nih.gov., Uchida N; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA.
Publikováno v: Stem cell research & therapy [Stem Cell Res Ther] 2020 Dec 17; Vol. 11 (1), pp. 544. Date of Electronic Publication: 2020 Dec 17.
Zobrazit plný text záznamu
6
Akademický článek
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation.
Autor: Demirci S; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Haro-Mora JJ; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Leonard A; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Drysdale C; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Malide D; Light Microscopy Core Facility, NHLBI, NIH, Bethesda, MD, USA., Keyvanfar K; Clinical Flow Core Facility, NHLBI, NIH, Bethesda, MD, USA., Essawi K; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA., Vizcardo R; National Cancer Institute, Center for Cancer Research, NIH, Bethesda, MD, USA., Tamaoki N; National Cancer Institute, Center for Cancer Research, NIH, Bethesda, MD, USA., Restifo NP; National Cancer Institute, Center for Cancer Research, NIH, Bethesda, MD, USA., Tisdale JF; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA. johntis@mail.nih.gov., Uchida N; Sickle Cell Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), 9000 Rockville Pike, Bldg. 10, 9N112, Bethesda, MD, 20892, USA.
Publikováno v: Stem cell research & therapy [Stem Cell Res Ther] 2020 Nov 24; Vol. 11 (1), pp. 493. Date of Electronic Publication: 2020 Nov 24.
Zobrazit plný text záznamu
7
Akademický článek
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells.
Autor: Good ML; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Vizcardo R; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH; vizcardo@nih.gov., Maeda T; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Tamaoki N; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Malekzadeh P; Surgery Branch, National Cancer Institute, NIH., Kawamoto H; Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University., Restifo NP; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH.
Publikováno v: Journal of visualized experiments : JoVE [J Vis Exp] 2019 Oct 24 (152). Date of Electronic Publication: 2019 Oct 24.
Zobrazit plný text záznamu
8
Akademický článek
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants.
Autor: Vizcardo R; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH; vizcardo@nih.gov., Rafiqul Islam SM; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Maeda T; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Tamaoki N; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Good ML; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Klemen ND; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Bosch-Marce M; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH., Jia L; Surgery Branch, National Cancer Institute, NIH., Kruhlak MJ; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH., Restifo NP; Surgery Branch, National Cancer Institute, NIH; Center for Cell-Based Therapy, National Cancer Institute, NIH.
Publikováno v: Journal of visualized experiments : JoVE [J Vis Exp] 2019 Aug 09 (150). Date of Electronic Publication: 2019 Aug 09.
Zobrazit plný text záznamu
9
Akademický článek
Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.
Autor: Vizcardo R; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Electronic address: vizcardo@nih.gov., Klemen ND; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Islam SMR; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Gurusamy D; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Tamaoki N; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Yamada D; Laboratory of Developmental Genetics, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa 230-0045, Japan., Koseki H; Laboratory of Developmental Genetics, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa 230-0045, Japan., Kidder BL; Department of Oncology and Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA., Yu Z; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Jia L; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Henning AN; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Good ML; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Bosch-Marce M; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Maeda T; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Liu C; Transgenic Core, Division of Intramural Research, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA., Abdullaev Z; Experimental Pathology Laboratory, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Pack S; Experimental Pathology Laboratory, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Palmer DC; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Stroncek DF; Department of Transfusion Medicine Department, Clinical Center, NIH, Bethesda, MD 20892, USA., Ito F; Department of Surgical Oncology, Roswell Park Cancer Center, Buffalo, NY 14263, USA; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Flomerfelt FA; Experimental Transplantation and Immunology Branch, NIH Clinical Center, NIH, Bethesda, MD 20892, USA., Kruhlak MJ; Experimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Restifo NP; Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Electronic address: restifo@nih.gov.
Publikováno v: Cell reports [Cell Rep] 2018 Mar 20; Vol. 22 (12), pp. 3175-3190.
Zobrazit plný text záznamu
10
Akademický článek
Human CD56+CD39+ dNK cells support fetal survival through controlling trophoblastic cell fate: immune mechanisms of recurrent early pregnancy loss.
Autor: Jia, Wentong1 (AUTHOR), Ma, Liyang1 (AUTHOR), Yu, Xin1,2,3 (AUTHOR), Wang, Feiyang1,2,3 (AUTHOR), Yang, Qian4 (AUTHOR), Wang, Xiaoye5 (AUTHOR), Fan, Mengjie5 (AUTHOR), Gu, Yan6 (AUTHOR), Meng, Ran7 (AUTHOR), Wang, Jian4 (AUTHOR), Li, Yuxia1 (AUTHOR), Li, Rong5 (AUTHOR) roseli001@sina.com, Shao, Xuan1,2,3 (AUTHOR) shaoxuan@ioz.ac.cn, Wang, Yan-Ling1,2,3 (AUTHOR) wangyl@ioz.ac.cn
Publikováno v: National Science Review. Jun2024, Vol. 11 Issue 6, p1-17. 17p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje